空カプセルの世界市場規模：エンドユーザー産業別、製品別、治療用途別、地域範囲別および予測

空カプセルの市場規模と予測

空カプセルの市場規模は、2024年に30億7,000万米ドルと評価され、2026～2032年にかけてCAGR 7.00%で成長し、2032年には50億2,000万米ドルに達すると予測されています。

空カプセルは、医薬品、化学品、粉末物質のための不可欠なキャリアとして機能し、医薬品、栄養補助食品、化粧品、ラボを含む様々な産業で広く利用されています。

固形剤形として機能するこれらのカプセルは、主に経口投与に使用され、医薬品有効成分（API）、ハーブ粉末、ビタミンサプリメントを収容します。

空カプセルの需要は、感染症やウイルス性疾患の有病率の上昇に加え、多方面にわたる用途の増加により拡大が見込まれています。

さらに、製薬能力の向上を目指した研究開発努力の高まりと、ヘルスケアへの公共投資と政府投資の増加が、今後数年間における空カプセルの市場拡大をさらに促進することになると考えられます。

空カプセルの世界市場力学

世界の空カプセル市場を形成している主要市場力学は以下の通りです。

主要市場促進要因

便利な剤形へのシフト：国際医薬品添加剤評議会による2022年の調査によると、消費者の68%が、飲み込みやすさと携帯性の良さから、他の経口剤形よりもカプセルを選んでいます。

ゼラチンフリーカプセルの需要増加：米国FDAは、2020～2022年にかけて、ベジタリアンカプセルを使用した新薬の承認が25%増加すると報告しています。

製薬産業の成長：WHOの報告によると、2021年の世界の医薬品研究開発費は2020年に比べて5.5%増加し、新薬の製剤を包装するための空カプセルの必要性がさらに高まっています。

主要課題

原料供給の課題：FAO（国連食糧農業機関）は、COVID-19パンデミックにより家畜の供給と食肉処理場の操業が中断したため、2019～2021年にかけて世界のゼラチン生産量が7.5%減少すると報告しました。

規制の複雑さ：米国FDAは2021年に、医薬品に使用されるゼラチン源のトレーサビリティと検証の強化を求める新ガイドラインを実施し、カプセル製造業者のコンプライアンスコスト増加につながりました。欧州医薬品庁は、空カプセルの組成と安全性に関する規制当局からの問い合わせ件数が2020～2022年にかけて12%増加したと報告し、新薬申請の承認プロセスを遅らせています。

代替剤との競合：国際医薬品添加剤評議会による2022年の消費者調査によると、回答者の28％がカプセル剤よりも口腔内崩壊錠を好み、その主要因として作用発現の速さを挙げています。

主要動向

ベジタリアン・植物性カプセルの需要増：International Pharmaceutical Excipients Councilによる2021年の調査では、世界の消費者の65%がサプリメントや医薬品にベジタリアンやヴィーガン向けのカプセルを積極的に求めていることがわかりました。

特殊カプセルの成長：米国FDAは、バイオアベイラビリティと患者体験を向上させるために製薬会社が技術革新を行っているため、特殊カプセル技術を利用した新薬申請が2020～2022年にかけて19%増加すると見ています。

ゼラチン代替品への需要の高まり：食生活、文化、宗教への配慮の高まりにより、ゼラチンを含まないカプセルへの嗜好が高まっています。この動向は、多様な消費者の嗜好と市場のニーズを反映しており、HPMCやプルランカプセルなどのベジタリアン向けオプションのような代替カプセル材料への需要を押し上げています。

目次

第1章 空カプセルの世界市場イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 空カプセルの世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析
• 規制の枠組み

第5章 空カプセルの世界市場：エンドユーザー産業別

• 概要
• 製薬産業
• 栄養補助食品産業
• 化粧品産業
• 臨床研究機関

第6章 空カプセルの世界市場：製品別

• 概要
• ゼラチン
• 非ゼラチン

第7章 空カプセルの世界市場：治療用途別

• 概要
• 抗生物質と抗菌薬
• ビタミンと栄養補助食品
• 制酸剤と整腸剤
• 抗炎症薬
• 抗血液製剤

第8章 空カプセルの世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋
• その他
  • ラテンアメリカ
  • 中東・アフリカ

第9章 空カプセルの世界市場の競合情勢

• 概要
• 企業市場ランキング
• ベンダー情勢
• 主要開発戦略

第10章 企業プロファイル

• Capsugel（現Lonza）
• ACG Worldwide
• Qualicaps
• Suheung Co. Ltd.
• CapsCanada Corporation
• Sunil Healthcare Limited
• Shanxi Guangsheng Medicinal Capsules Co. Ltd
• Bright Pharma Caps, Inc.
• Snail Pharma Industry Co. Ltd.
• Natural Capsules Limited

第11章 主要開発

• 製品の上市/開発
• 合併と買収
• 事業拡大
• パートナーシップと提携

第12章 付録

• 関連調査

Empty Capsules Market Size And Forecast

Empty Capsules Market size was valued at USD 3.07 Billion in 2024 and is projected to reach USD 5.02 Billion by 2032, growing at a CAGR of 7.00% from 2026 to 2032.

Empty capsules serve as essential carriers for pharmaceutical drugs, chemicals, and powdered substances, widely utilized in various industries including pharmaceuticals, nutraceuticals, cosmetics, and research laboratories.

Acting as solid dosage forms, these capsules are primarily used for oral administration, housing active pharmaceutical ingredients (APIs), herbal powders, and vitamin supplements.

The demand for empty capsules is expected to grow due to the rising prevalence of infectious and viral diseases, along with their increasing application across multiple sectors.

Additionally, heightened research and development efforts aimed at advancing pharmaceutical capabilities, coupled with growing public and government investments in healthcare, are set to further drive market expansion for empty capsules in the coming years.

Global Empty Capsules Market Dynamics

The key market dynamics that are shaping the global empty capsules market include:

Key Market Drivers:

Shift Towards Convenient Dosage Forms: A 2022 survey by the International Pharmaceutical Excipients Council found that 68% of consumers chose capsules over other oral dosage forms due to their ease of swallowing and portability.

Increasing Demand for Gelatin-Free Capsules: The U.S. FDA reported a 25% increase in approvals for new drug applications using vegetarian capsules from 2020 to 2022, driven by growing consumer demand for plant-based and vegan-friendly options.

Pharmaceutical Industry Growth: The WHO reported that global pharmaceutical R&D spending increased by 5.5% in 2021 compared to 2020, further fueling the need for empty capsules to package new drug formulations.

Key Challenges:

Raw Material Supply Challenges: The Food and Agriculture Organization (FAO) reported a 7.5% decrease in global gelatin production from 2019 to 2021, as the COVID-19 pandemic disrupted livestock supplies and slaughterhouse operations.

Regulatory Complexity: The U.S. FDA implemented new guidelines in 2021 requiring enhanced traceability and verification for gelatin sources used in pharmaceutical products, leading to increased compliance costs for capsule producers. The European Medicines Agency reported a 12% increase in the number of regulatory queries related to empty capsule composition and safety from 2020 to 2022, slowing the approval process for new drug applications.

Competition from Alternative Delivery Forms: A 2022 consumer survey by the International Pharmaceutical Excipients Council found that 28% of respondents preferred orally disintegrating tablets over capsules, citing faster onset of action as a key driver.

Key Trends:

Rising Demand for Vegetarian & Plant-Based Capsules: A 2021 survey by the International Pharmaceutical Excipients Council found that 65% of consumers globally actively seek out vegetarian or vegan-friendly capsule options for supplements and medications.

Growth of Specialty Capsule Formats: The U.S. FDA saw a 19% increase in new drug applications utilizing specialized capsule technologies from 2020 to 2022, as pharmaceutical companies innovate to improve bioavailability and patient experience.

Increasing Demand for Gelatin Alternatives: Growing dietary, cultural, and religious considerations are leading to a rising preference for gelatin-free capsules. This trend reflects diverse consumer preferences and market needs, boosting demand for alternative capsule materials like vegetarian options, including HPMC and pullulan capsules.

Global Empty Capsules Market Regional Analysis

Here is a more detailed regional analysis of the global empty capsules market:

North America

North America substantially dominates the global empty capsules market driven by the large pharmaceutical industry and R&D investments.

According to the IQVIA Institute, the North American pharmaceutical market was valued at USD 612 Billion in 2020, accounting for nearly half of the global market.

The U.S. National Institutes of Health reported a 7.5% year-over-year increase in pharmaceutical R&D spending in the North American region from 2020 to 2021, reaching over USD 300 Billion.

A 2022 survey by the International Pharmaceutical Excipients Council revealed that 72% of North American consumers prefer purchasing medications in specialty capsule formats like gastro-resistant or controlled-release.

The U.S. Council for Responsible Nutrition reported that the North American nutraceuticals market reached USD 60 Billion in 2021, a 7.5% increase from 2020 levels.

Health Canada data shows that the value of natural health product licenses, which often utilize empty capsules, grew by 9% in the country from 2020 to 2022.

Asia Pacific

Asia Pacific is anticipated to witness the fastest growth in the empty capsules market during the forecast period owing to the expanding pharmaceutical and nutraceuticals industry.

According to the India Brand Equity Foundation, the Indian pharmaceutical industry grew by 18.8% in 2021 to reach $42 billion, driving greater demand for empty capsules.

A 2022 report by the Japan Health and Nutrition Food Association found that the Japanese nutraceuticals market reached $30 billion, up 12% from 2020 levels.

The China Vegetarian Association reported a 20% increase in the sales of plant-based supplements packaged in vegetarian capsules from 2020 to 2022.

A 2021 survey by the International Pharmaceutical Excipients Council found that 68% of consumers in the Asia Pacific region actively seek out clean-label and non-animal-derived capsule products.

The OECD reported that China's per capita healthcare expenditure grew by 9.2% annually from 2020 to 2022, improving access to medicines packaged in empty capsules.

The Indian government's 2022 budget allocated $10 billion towards expanding the country's universal healthcare coverage, which is expected to drive greater pharmaceutical consumption.

Global Empty Capsules Market: Segmentation Analysis

The Global Empty Capsules Market is segmented based on End-User Industry, Product, Therapeutic Application, And Geography.

Empty Capsules Market, By End-User Industry

• Pharmaceutical Industry
• Nutraceutical Industry
• Cosmetics Business
• Clinical Research Organization

Based on the End-User Industry, the Global Empty Capsules Market is bifurcated into the Pharmaceutical Industry, Nutraceutical Industry, Cosmetics Business, and Clinical Research Organization. The Pharmaceutical segment is experiencing growth in the Global Empty Capsules Market owing to the increasing production and usage of a wide range of drugs by healthcare practitioners. Empty capsules are extensively utilized in the pharmaceutical industry for the treatment of infectious and chronic diseases, as they help extend the shelf life of active ingredients in medications.

Empty Capsules Market, By Product

• Gelatin
• Non-Gelatin

Based on the Product, the Global Empty Capsules Market is bifurcated into Gelatin and Non-Gelatin. The Gelatin segment dominates in the Global Empty Capsules Market. The gelatin-based empty capsules are made from various sources, including pig meat gelatin, bovine-derived gelatin, and bone meal gelatin. These capsules are composed of pure protein, are tasteless, and are both gluten-free and GMO-free. Furthermore, they are customized in terms of color, shape, and size to meet specific needs and accommodate diverse demographics.

Empty Capsules Market, By Therapeutic Application

• Antibiotic and Antibacterial Drugs
• Vitamins and Dietary Supplements
• Antacid and Antiflatulent Preparations
• Anti-inflammatory Drugs
• Antianemic Preparations

Based on the Therapeutic Application, the Global Empty Capsules Market is bifurcated into Antibiotic and Antibacterial Drugs, Vitamins and Dietary Supplements, Antacid and Antiflatulent Preparations, Anit-inflammatory Drugs, and Antianemic Preparations. The Antibiotic and Antibacterial Drugs segment dominates in the Global Empty Capsules Market owing to high demand for commonly used drugs such as penicillin, tetracycline, sulfonamide, and nitrofurantoin. Rising cases of bacterial infections, including tuberculosis, and bladder, and gastrointestinal infections, continue to drive demand for these medications. Additionally, ongoing research and development in antibiotic and antibacterial drugs further support market growth.

Key Players

The "Global Empty Capsules Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Capsugel (now Lonza), ACG Worldwide, Qualicaps, Suheung Co., Ltd., CapsCanada Corporation, Sunil Healthcare Limited, Shanxi Guangsheng Medicinal Capsules Co., Ltd., Bright Pharma Caps, Inc., Snail Pharma Industry Co., Ltd., Natural Capsules Limited.

• This section offers in-depth analysis through a company overview, position analysis, the regional and industrial footprint of the company, and the ACE matrix for insightful competitive analysis. The section also provides an exhaustive analysis of the financial performances of mentioned players in the given market.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Empty Capsules Market Key Developments

• In March 2023, VANTAGE NUTRITION, an ACG company, announced the acquisition of ComboCap, Inc. in the United States and BioCap in South Africa, with plans to grow their technology and footprint in North America and around the world.
• In January 2022, Xi'an Le-Nutra Ingredients Inc. exported 8.0 million HPMC capsules to Latvia, Europe. These capsules did not contain titanium dioxide (TiO2), reflecting the company's efforts to accommodate regional demand for the product.
• In July 2020, QUALICAPS Group, which was previously part of Mitsubishi Chemical Holdings Corporation (MCHC), was transferred to Mitsubishi Chemical Corporation (MCC). This transition enables QUALICAPS to make use of its network and increase its capsule business.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL EMPTY CAPSULES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL EMPTY CAPSULES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis
• 4.5 Regulatory Framework

5 GLOBAL EMPTY CAPSULES MARKET, BY END-USER INDUSTRY

• 5.1 Overview
• 5.2 Pharmaceutical Industry
• 5.3 Nutraceutical Industry
• 5.4 Cosmetics Business
• 5.5 Clinical Research Organization

6 GLOBAL EMPTY CAPSULES MARKET, BY PRODUCT

• 6.1 Overview
• 6.2 Gelatin
• 6.3 Non-Gelatin

7 GLOBAL EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION

• 7.1 Overview
• 7.2 Antibiotic and Antibacterial Drugs
• 7.3 Vitamins and Dietary Supplements
• 7.4 Antacid and Antiflatulent Preparations
• 7.5 Anti-inflammatory Drugs
• 7.6 Antianemic Preparations

8 GLOBAL EMPTY CAPSULES MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL EMPTY CAPSULES MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market ranking
• 9.3 Vendor Landscape
• 9.4 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Capsugel (now Lonza)
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 ACG Worldwide
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Qualicaps
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Suheung Co. Ltd.
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 CapsCanada Corporation
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Sunil Healthcare Limited
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Shanxi Guangsheng Medicinal Capsules Co. Ltd
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Bright Pharma Caps, Inc.
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Snail Pharma Industry Co. Ltd.
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Natural Capsules Limited
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 APPENDIX

• 12.1 Related Research